Evaluation of safety profile of thoracoscopic esophagectomy for T1bN0M0 cancer using data from JCOG0502: a prospective multicenter study
Isao Nozaki(National Hospital Organization), Yuko Kitagawa(Keio University), Harushi Udagawa(Okinaka Memorial Adult Disease Research Institute), Hiroyasu Igaki(Apple (Israel)), Junki Mizusawa(Japan Clinical Cancer Research Organization), Kenichi Nakamura, Hiroyuki Daiko(Juntendo University), Yoshinori Ito(National Cancer Center Hospital East), Hiroshi Katayama, Ken Kato(National Cancer Center Hospital East), Masahiko Yano(Nagoya Sangyo University)
Cited by 43
Related Papers
Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2016 for the treatment of colorectal cancer
|International Journal of Clinical Oncology|2017|2.5k
Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2019 for the treatment of colorectal cancer
|International Journal of Clinical Oncology|2019|2k
Randomized Phase III KEYNOTE-181 Study of Pembrolizumab Versus Chemotherapy in Advanced Esophageal Cancer
|Journal of Clinical Oncology|2020|1.2k
Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2010 for the treatment of colorectal cancer
|International Journal of Clinical Oncology|2011|713
Japanese Society for Cancer of the Colon and Rectum (JSCCR) Guidelines 2014 for treatment of colorectal cancer
|International Journal of Clinical Oncology|2015|600